TEVA

New York Stock Exchange

Teva Pharmaceutical Industries Ltd. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$42.21B

PE Ratio

28.7884

EV to Ebitda

10.8768

Earnings Yield

3.47%

Revenue (TTM)

$17.41B

Net Income (TTM)

$1.43B

Revenue (Annual YoY Growth)

5.26%

Revenue (Quarterly YoY Growth)

12.42%

Profit Margin

8.20%

Return on Equity

20.99%

Debt to Equity Ratio

2.1731

Dividend Yield

0.00%

All fundamentals

Core9 fields›

Market Cap$42.21B

Revenue TTM$17.41B

Shares Outstanding1.16B

Float1120890231

Float Short2.62%

Days To Cover5.3960525436

Short Interest29602709.0

Relative Strength85.2

GARP3878

Growth Estimates17 fields›

Revenue Growth (Annual)5.26%

Revenue Growth (Quarterly YoY)12.42%

Operating Revenue Growth (Annual)-0.003397

Operating Revenue Growth (Quarterly YoY)0.015357

3-Year Revenue Growth5.53%

5-Year Revenue Growth0.94%

EPS Growth (Annual)183.93%

EPS Growth (Quarterly YoY)313.26%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates4.07%

EBITDA Growth (Annual)14.74%

EBITDA Growth (Quarterly YoY)33.16%

CFO Growth (Annual)13.16%

CFO Growth (Quarterly YoY)83.84%

FCF Growth (Annual)16.15%

FCF Growth (Quarterly YoY)95.77%

Operations28 fields›

Revenue TTM$17.41B

Gross Margin TTM51.82%

Gross Margin (Quarterly)56.49%

R&D % of Revenue TTM5.87%

R&D Expenses TTM$1.02B

Operating Margin TTM22.95%

Operating Margin (Quarterly)27.13%

Operating Expenses TTM$5.03B

Profit Margin TTM8.20%

Profit Margin (Quarterly)10.16%

Net Income TTM$1.43B

EPS TTM1.2182

EPS (Quarterly)0.4118

EBIT Margin TTM22.95%

EBIT Margin (Quarterly)27.13%

EBITDA Margin TTM28.77%

EBITDA Margin (Quarterly)32.63%

EBITDA TTM$5.01B

CFO % of Revenue TTM16.53%

CFO % of Revenue (Quarterly)35.38%

CFO TTM$1.51B

Cash Margin5.22%

Capex % of Revenue TTM2.90%

Capital Expenditures$505.0M

FCF % of Revenue TTM13.64%

FCF % of Revenue (Quarterly)32.36%

FCF TTM$1.00B

Fundamental Score3

Efficiency6 fields›

ROE20.99%

ROA3.60%

ROIC5.90%

CROCI4.15%

Stock Comp % (Quarterly)1.08%

Stock Comp % TTM0.91%

Valuation20 fields›

P/E (TTM)28.7884

P/E Forward14.2942

P/E Ex-Cash26.2816

P/S Forward2.4665

PEG Forward0.1418

P/CFO27.06

P/FCF40.6716

EV/EBITDA (TTM)10.8768

EV/EBITDA Forward11.2725

EV/Revenues (TTM)3.129

EV/Revenues Forward3.2902

EV/CFO32.8208

EV/FCF (TTM)54.2616

Price To Book5.1627

Price to Tangible Book-0.5296

Earnings Yield3.47%

FCF Yield2.46%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score3

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.0377

Relative Profit Margin (Quarterly)1.8914

Relative P/E1.4488

Relative P/S1.0366

Relative P/B2.0923

Relative Earnings Yield0.6902

Relative Dividend Yield0

Relative ROE1.519

Relative ROA0.6356

Relative ROIC0.7776

Relative Debt to Equity3.4708

Liquidity15 fields›

Cash Per Share3.0921

Current Ratio1.0364

Cash & ST Assets$3.56B

Total Debt$17.07B

Goodwill & Intangibles$19.78B

Total Assets$40.75B

Total Liabilities$32.83B

Shareholders Equity$7.91B

Debt to Equity2.1731

Debt to Assets42.18%

Interest Expense$1.03B

Times Interest Earned3.8738

CFO to Debt (TTM)0.0868

Debt to EBITDA (TTM)3.4699

Goodwill % of Assets48.54%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield3.47%

Buyback Yield0.00%

Shareholder Yield1.16%

Options Flow8 fields›

Call Volume2586

Put Volume277

Put/Call Ratio0.10711523588553751

Call $ Volume601765

Put $ Volume20848

Put/Call $ Ratio0.034644753350560435

Call OI346205

Put OI176839